British Journal of Cancer - Table of Contents alert Volume 116 Issue 12

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 116, Issue 12 (1499-1659) Published online 6 June 2017 In this issue Minireview Clinical Studies Translational Therapeutics Molecular Diagnostics Genetics & Genomics Epidemiology Also new today Advance online publication Digital Edition Follow us on Twitter Sign up for e-alerts Recommend to your library Web feed Subscribe Minireview Top One-carbon metabolism in cancer Alice C Newman and Oliver D K Maddocks Br J Cancer 2017 116: 1499-1504; advance online publication, May 4, 2017; 10.1038/bjc.2017.118 Abstract | Full Text Clinical Studies Top Phase I dose-escalation studies of roniciclib, a pan-cyclin-dependent kinase inhibitor, in advanced malignancies Rastislav Bahleda, Juneko E Grilley-Olson, Ramaswamy Govindan, Fabrice Barlesi, Laurent Greillier, Maurice Perol, Isabelle Ray-Coquard, Dirk Strumberg, Beate Schultheis, Grace K Dy, Gérard Zalcman, Glen J Weiss, Annette O Walter, Martin Kornacker, Prabhu Rajagopalan, David Henderson, Hendrik Nogai, Matthias Ocker and Jean-Charles Soria Br J Cancer 2017 116: 1505-1512; advance online publication, May 2, 2017; 10.1038/bjc.2017.92 Abstract | Full Text A meta-analysis comparing the risk of metastases in patients with rectal cancer and MRI-detected extramural vascular invasion (mrEMVI) vs mrEMVI-negative cases Muhammed R S Siddiqui, Constantinos Simillis, Chris Hunter, Manish Chand, Jemma Bhoday, Aurelie Garant, Te Vuong, Giovanni Artho, Shahnawaz Rasheed, Paris Tekkis, Al-Mutaz Abulafi and Gina Brown Br J Cancer 2017 116: 1513-1519; advance online publication, April 27, 2017; 10.1038/bjc.2017.99 Abstract | Full Text Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study Luca Triggiani, Filippo Alongi, Michela Buglione, Beatrice Detti, Riccardo Santoni, Alessio Bruni, Ernesto Maranzano, Frank Lohr, Rolando D’Angelillo, Alessandro Magli, Alberto Bonetta, Rosario Mazzola, Nadia Pasinetti, Giulio Francolini, Gianluca Ingrosso, Fabio Trippa, Sergio Fersino, Paolo Borghetti, Paolo Ghirardelli and Stefano Maria Magrini Br J Cancer 2017 116: 1520-1525; advance online publication, April 27, 2017; 10.1038/bjc.2017.103 Abstract | Full Text Nomogram-based prediction of survival in patients with advanced oesophagogastric adenocarcinoma receiving first-line chemotherapy: a multicenter prospective study in the era of trastuzumab A Custodio, A Carmona-Bayonas, P Jiménez-Fonseca, M L Sánchez, A Viudez, R Hernández, J M Cano, I Echavarria, C Pericay, M Mangas, L Visa, E Buxo, T García, A Rodríguez Palomo, F Álvarez Manceñido, A Lacalle, I Macias, A Azkarate, A Ramchandani, A Fernández Montes, C López, F Longo, R Sánchez Bayona, M L Limón, A Díaz-Serrano, A Hurtado, R Madero, C Gómez and J Gallego on behalf of the AGAMENON study group Br J Cancer 2017 116: 1526-1535; advance online publication, May 2, 2017; 10.1038/bjc.2017.122 Abstract | Full Text Comorbid conditions delay diagnosis of colorectal cancer: a cohort study using electronic primary care records Luke T A Mounce, Sarah Price, Jose M Valderas and William Hamilton Br J Cancer 2017 116: 1536-1543; advance online publication, May 11, 2017; 10.1038/bjc.2017.127 Abstract | Full Text Efficacy and safety of gemcitabine plus S-1 in pancreatic cancer: a pooled analysis of individual patient data Chikuma Hamada, Takuji Okusaka, Takaaki Ikari, Hiroyuki Isayama, Junji Furuse, Hiroshi Ishii, Yousuke Nakai, Shogo Imai and Shota Okamura Br J Cancer 2017 116: 1544-1550; advance online publication, May 4, 2017; 10.1038/bjc.2017.128 Abstract | Full Text GP participation in increasing uptake in a national bowel cancer screening programme: the PEARL project Sally C Benton, Piers Butler, Katy Allen, Michelle Chesters, Sally Rickard, Sally Stanley, Richard Roope, Daniel Vulkan and Stephen W Duffy Br J Cancer 2017 116: 1551-1557; advance online publication, May 18, 2017; 10.1038/bjc.2017.129 Abstract | Full Text Translational Therapeutics Top Efficacy of anti-PD-1 therapy in patients with melanoma brain metastases Sagun Parakh, John J Park, Shehara Mendis, Rajat Rai, Wen Xu, Serigne Lo, Martin Drummond, Catherine Rowe, Annie Wong, Grant McArthur, Andrew Haydon, Miles C Andrews, Jonathan Cebon, Alex Guminski, Richard F Kefford, Georgina V Long, Alexander M Menzies, Oliver Klein and Matteo S Carlino Br J Cancer 2017 116: 1558-1563; advance online publication, May 18, 2017; 10.1038/bjc.2017.142 Abstract | Full Text Molecular Diagnostics Top Mutation status among patients with sinonasal mucosal melanoma and its impact on survival Moran Amit, Samantha Tam, Ahmed S Abdelmeguid, Dianna B Roberts, Yoko Takahashi, Shaan M Raza, Shirley Y Su, Michael E Kupferman, Franco DeMonte and Ehab Y Hanna Br J Cancer 2017 116: 1564-1571; advance online publication, May 11, 2017; 10.1038/bjc.2017.125 Abstract | Full Text Inhibition of neurotensin receptor 1 induces intrinsic apoptosis via let-7a-3p/Bcl-w axis in glioblastoma Zhen Dong, Qian Lei, Rui Yang, Shunqin Zhu, Xiao-Xue Ke, Liqun Yang, Hongjuan Cui and Liang Yi Br J Cancer 2017 116: 1572-1584; advance online publication, May 11, 2017; 10.1038/bjc.2017.126 Abstract | Full Text BAG-1 as a biomarker in early breast cancer prognosis: a systematic review with meta-analyses E S Papadakis, T Reeves, N H Robson, T Maishman, G Packham and R I Cutress Br J Cancer 2017 116: 1585-1594; advance online publication, May 16, 2017; 10.1038/bjc.2017.130 Abstract | Full Text Clinical value of R-spondins in triple-negative and metaplastic breast cancers F Coussy, F Lallemand, S Vacher, A Schnitzler, W Chemlali, M Caly, A Nicolas, S Richon, D Meseure, R El Botty, L De-Plater, L Fuhrmann, T Dubois, S Roman-Roman, V Dangles-Marie, E Marangoni and I Bièche Br J Cancer 2017 116: 1595-1603; advance online publication, May 4, 2017; 10.1038/bjc.2017.131 Abstract | Full Text Human papillomavirus association is the most important predictor for surgically treated patients with oropharyngeal cancer Steffen Wagner, Claus Wittekindt, Shachi Jenny Sharma, Nora Wuerdemann, Theresa Jüttner, Miriam Reuschenbach, Elena-Sophie Prigge, Magnus von Knebel Doeberitz, Stefan Gattenlöhner, Ernst Burkhardt, Jörn Pons-Kühnemann and Jens Peter Klussmann Br J Cancer 2017 116: 1604-1611; advance online publication, May 4, 2017; 10.1038/bjc.2017.132 Abstract | Full Text The differential expression of omega-3 and omega-6 fatty acid metabolising enzymes in colorectal cancer and its prognostic significance Abdo Alnabulsi, Rebecca Swan, Beatriz Cash, Ayham Alnabulsi and Graeme I Murray Br J Cancer 2017 116: 1612-1620; advance online publication, May 30, 2017; 10.1038/bjc.2017.135 Abstract | Full Text Genetics & Genomics Top Sequencing of DICER1 in sarcomas identifies biallelic somatic DICER1 mutations in an adult-onset embryonal rhabdomyosarcoma Leanne de Kock, Barbara Rivera, Timothée Revil, Paul Thorner, Catherine Goudie, Dorothée Bouron-Dal Soglio, Catherine S Choong, John R Priest, Paul J van Diest, Jantima Tanboon, Anja Wagner, Jiannis Ragoussis, Peter FM Choong and William D Foulkes Br J Cancer 2017 116: 1621-1626; advance online publication, May 18, 2017; 10.1038/bjc.2017.147 Abstract | Full Text Epidemiology Top Pre-diagnosis diet and survival after a diagnosis of ovarian cancer Mary C Playdon, Christina M Nagle, Torukiri I Ibiebele, Leah M Ferrucci, Melinda M Protani, Jonathan Carter, Simon E Hyde, Deborah Neesham, James L Nicklin, Susan T Mayne and Penelope M Webb for the Australian Ovarian Cancer Study Group Br J Cancer 2017 116: 1627-1637; advance online publication, May 2, 2017; 10.1038/bjc.2017.120 Abstract | Full Text The contribution of body mass index to appraisal delay in colorectal cancer diagnosis: a structural equation modelling study Karen E Dyer, Levent Dumenci, Laura A Siminoff, Maria D Thomson and Jennifer Elston Lafata Br J Cancer 2017 116: 1638-1642; advance online publication, May 2, 2017; 10.1038/bjc.2017.123 Abstract | Full Text Herpes zoster risk after 21 specific cancers: population-based case–control study Erik Hansson, Harriet J Forbes, Sinéad M Langan, Liam Smeeth and Krishnan Bhaskaran Br J Cancer 2017 116: 1643-1651; advance online publication, May 2, 2017; 10.1038/bjc.2017.124 Abstract | Full Text Statin use, candidate mevalonate pathway biomarkers, and colon cancer survival in a population-based cohort study Ronan T Gray, Maurice B Loughrey, Peter Bankhead, Chris R Cardwell, Stephen McQuaid, Roisin F O'Neill, Kenneth Arthur, Victoria Bingham, Claire McGready, Anna T Gavin, Jacqueline A James, Peter W Hamilton, Manuel Salto-Tellez, Liam J Murray and Helen G Coleman Br J Cancer 2017 116: 1652-1659; advance online publication, May 18, 2017; 10.1038/bjc.2017.139 Abstract | Full Text Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Springer Nature's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2017 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.